Report copyright - The cisplatin-based Pt(IV)-diclorofibrato multi-action ... · S1 The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also in
Please pass captcha verification before submit form
Please pass captcha verification before submit form